Sirna mediated post-transriptional gene silencing of genes involved in alopecia
OwnerShaharyar Khaninventor
Life of this patent
Estimating the term…
Loading patent…
OwnerShaharyar Khaninventor
Estimating the term…
Compositions and methods for the use of inhibitory nucleic acids, for example small inhibitory ribonucleic acids (siRNA), to adjust, manipulate, prevent, inhibit, interfere, or block the androgen signal transduction pathway in a host cell, for example in a host's hair cell are provided. Aspects of the disclosure provide compositions and methods for interfering with the androgen signal transduction pathway by down regulating the expression of proteins involved in the androgen signal transduction pathway. Exemplary gene targets encoding proteins involved in the androgen signal transduction pathway include but are not limited to isozymes I and II of 5-α reductase, the androgen receptor, aromatase, 3-α-hydroxysteroiddehydrogenase, 3-β-hydroxysteroiddehydrogenase , 3-β-hydroxysteroiddehydrogenase-4-5-isomerase, 17-β-hydroxysteroidoxidoreductase, and steroid sulfatase. In some aspects, the inhibitory nucleic acids, for example siRNAs, interfere with the expression of targeted genes by preventing, reducing, or inhibiting the translation of mRNA transcribed from the targeted gene.
A method of reducing hair loss in a mammal comprising the step of:
A method of reducing hair loss in mammal comprising the step of:
A method of treating alopecia comprising the step of:
A method of inducing hair growth comprising the step of:
A method of promoting hair growth or decreasing hair loss, said method comprising the steps of:
An inhibitory nucleic acid comprising:
A vector comprising:
A cell comprising:
A method of treating hair loss in a mammal comprising reducing the levels of dihydroxy testosterone in the mammal by contacting the mammal with an effective amount of inhibitory nucleic acid specific for 5-a-reductase, wherein the effective amount of inhibitory nucleic acid specific for 5-a-reductase inhibits the expression of 5-a reductase protein.
A method of reducing testosterone metabolites in a cell comprising contacting the cell with an amount of inhibitory nucleic acid specific for 5-a-reductase sufficient to reduce the levels of 5-a reductase protein in the cell.
Dependencies are inferred from the claim text.